Oncology Institute, Inc.

The Oncology Institute, Inc. (Nasdaq: TOI) is a community-based oncology services provider that completed its de-SPAC merger with DFB Healthcare Acquisitions Corp. in late 2022. The blank-check vehicle, sponsored by DFB Capital Partners and focused on the healthcare sector, conducted its initial public offering in 2021. Following the business combination, TOI operated a network of value-based oncology clinics across multiple U.S. states. The company filed a Form 8-K current report with the SEC on May 8, 2025, continuing its public-disclosure obligations as a post-merger reporting entity. For full filing history, merger terms, and real-time SPAC analytics on TOI and hundreds of other de-SPAC companies, sign up for complete data on SpacDesk.